Atlas Trials

A Single Intravitreal Injection of rAAV2-ND4 for the Treatment of Leber's Hereditary Optic Neuropathy

Clinical trial NCT03153293 · UNKNOWN

Trial details

NCT number
NCT03153293
Sponsor
Huazhong University of Science and Technology
Status
UNKNOWN
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Leber Hereditary Optic Neuropathy
Start date
2017-12-27
Primary completion
2020-01-15
Enrollment
159

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.